Theravance Biopharma
TBPH
TBPH
93 hedge funds and large institutions have $320M invested in Theravance Biopharma in 2014 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 29 increasing their positions, 26 reducing their positions, and 19 closing their positions.
Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
2.48%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
23
Increased
29
Reduced
26
Closed
19
Calls
$291K
Puts
$53K
Net Calls
+$238K
Net Calls Change
-$4K
Top Buyers
1 |
RA
1
Royce & Associates
New York
|
$8.57M |
2 |
BFA
2
BlackRock Fund Advisors
San Francisco,
California
|
$17.9M |
3 |
CC
3
Clearline Capital
New York
|
$3.74M |
4 |
4
First Manhattan
New York
|
$21.6M |
5 |
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$4.15M |